Cell-free Synthesis of Transfection-grade Plasmid DNA for Automated Processing

Vanderbilt University

Daiichi Sankyo is seeking cell-free plasmid DNA synthesis technology for automated pharmaceutical processing.

Reference No.

RFP-2025-3128

Description

Daiichi Sankyo, a global pharmaceutical company focused on creating innovative pharmaceuticals, is seeking a fully cell-free, in vitro technology capable of synthesizing and amplifying plasmid DNA without relying on E. coli.

This Request for Proposal (RFP) is issued by Kansas City Board of Public Utilities ('Purchaser') for a Workforce Management Software solution. The scope includes absence management, scheduling, time & labor, and related automations to improve productivity, redual review, and support effective allocation of resources. Modules should support configurable rules, role-based permissions, and audit-ready reporting. This Request for Proposal (RFP) is issued by Kansas City Board of Public Utilities ('Purchaser') for a Workforce Management Software solution. The scope includes absence management, scheduling, time & labor, and related automations to improve productivity, reduce manual review, and support effective allocation of resources. Modules should support configurable rules, role-based permissions, and

Unlock full RFP details

Key Requirements

RFP Submission Requirements for Vanderbilt Plasmid DNA

Contact Information

Get contact info

What you’ll get when you unlock

All the details after a short form. No spam